[Symposium 106] Oral Splint Therapy for Tourette Syndrome: Bridging Dentistry and Psychiatry

[SY-106] Oral Splint Therapy for Tourette Syndrome: Bridging Dentistry and Psychiatry

Jumpei Murakami¹, Kyoko Hoshino², Yoshihisa Tachibana³, Max A Tischfield⁴ (1.Osaka University(Japan), 2.Segawa Memorial Neurological Clinic for Children(Japan), 3.Kobe University(Japan), 4.Rutgers University(United States of America))

Keywords:

Tourette Syndrome,Tic,Oral Splint

Tourette syndrome (TS) is a complex neuropsychiatric disorder characterized by repetitive, involuntary movements and vocalizations known as tics. Although pharmacological and behavioral therapies are commonly used, their effectiveness varies among individuals, and side effects can be burdensome. Recently, oral splint therapy has emerged as a promising intervention, showing potential in reducing tic symptoms. Despite this growing interest, the underlying mechanisms of its therapeutic effects remain unclear. This symposium aims to explore the potential and challenges of oral splint therapy for Tourette syndrome from a multidisciplinary perspective. By bringing together experts from dentistry, neurology, and neuroscience, we will discuss the clinical efficacy of dental splint therapy, its neurological implications, and possible underlying mechanisms. Through this interdisciplinary dialogue, we aim to deepen the understanding of oral splint therapy's role in managing TS and encourage further research and collaboration. Through this symposium, we will examine the clinical and scientific foundations of oral splint therapy for Tourette syndrome. The presentations will include a comprehensive review of clinical outcomes, neurological insights into tic modulation, and hypotheses on the neural mechanisms involved. By fostering collaboration between clinicians and researchers, we hope to inspire innovative therapeutic strategies and pave the way for evidence-based integration of oral splint therapy into TS management.